JavaScript is NOT enabled !

Please enable JavaScript.

Article

FT
PubMed

This record comes from PubMed

Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma

Kaiser, Martin
Author Kaiser, Martin Department of Haematology, The Royal Marsden Hospital, London, UK. Martin.Kaiser@icr.ac.uk Division of Molecular Pathology, The Institute of Cancer Research (ICR) and The Royal Marsden Hospital, 123 Old Brompton Road, London, SW7 3RP, UK. Martin.Kaiser@icr.ac.uk
Beksaç, Meral
Author Beksaç, Meral Department of Hematology, Ankara University, Ankara, Turkey
Gulbrandsen, Nina
Author Gulbrandsen, Nina Oslo Myeloma Center, Oslo University Hospital, and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
Schjesvold, Fredrik
Author Schjesvold, Fredrik Oslo Myeloma Center, Oslo University Hospital, and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
Hájek, Roman
Author Hájek, Roman Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic
Moreau, Philippe
Author Moreau, Philippe Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France
de la Fuente, Felipe de Arriba
Author de la Fuente, Felipe de Arriba Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer y Centro Regional de Hemodonación, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain
Mateos, María-Victoria
Author Mateos, María-Victoria Department of Hematology, University Hospital of Salamanca, CIC, IBM CC, Salamanca, Spain
West, Sharon
Author West, Sharon Department of Haematology, The Royal Marsden Hospital, London, UK
Spencer, Andrew
Author Spencer, Andrew Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, Australia
Rajkumar, S Vincent
Author Rajkumar, S Vincent Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Suryanarayan, Kaveri
Author Suryanarayan, Kaveri Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA
Czorniak, Michael
Author Czorniak, Michael Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA
Li, Cong
Author Li, Cong Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA
Teng, Zhaoyang
Author Teng, Zhaoyang Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA
Labotka, Richard
Author Labotka, Richard Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA
Dimopoulos, Meletios A
Author Dimopoulos, Meletios A Hematology and Medical Oncology, Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Annals of hematology. 2021 Jan ; 100 (1) : 297-302.

Ann Hematol
ISSN 1432-0584 | 0939-5555
Source

Status PubMed-not-MEDLINE Language English Country Germany Media print

Document type Published Erratum

Persistent link https://www.medvik.cz/link/pmid33106909

Online Full text

PubMed 33106909
PubMed Central PMC7852957
DOI 10.1007/s00277-020-04302-0
PII: 10.1007/s00277-020-04302-0
Knihovny.cz E-resources

Publication type
Published Erratum MeSH

Department of Haematology The Royal Marsden Hospital London UK

Department of Hematology Ankara University Ankara Turkey

Department of Hematology University Hospital Hôtel Dieu Nantes France

Department of Hematology University Hospital of Salamanca CIC IBM CC Salamanca Spain

Department of Hematooncology University Hospital Ostrava Ostrava Czech Republic

Division of Hematology Department of Internal Medicine Mayo Clinic Rochester MN USA

Division of Molecular Pathology The Institute of Cancer Research and The Royal Marsden Hospital 123 Old Brompton Road London SW7 3RP UK

Hematology and Medical Oncology Department of Clinical Therapeutics School of Medicine National and Kapodistrian University of Athens Athens Greece

Malignant Haematology and Stem Cell Transplantation Service Alfred Health Monash University Melbourne Australia

Millennium Pharmaceuticals Inc a wholly owned subsidiary of Takeda Pharmaceutical Company Limited Cambridge MA USA

Oslo Myeloma Center Oslo University Hospital and KG Jebsen Center for B Cell Malignancies University of Oslo Oslo Norway

Servicio de Hematología y Oncología Médica Hospital Universitario Morales Meseguer y Centro Regional de Hemodonación IMIB Arrixaca Universidad de Murcia Murcia Spain

Erratum For

Ann Hematol. 2020 Aug;99(8):1793-1804. doi: 10.1007/s00277-020-04149-5. PubMed

References provided by Crossref.org

Borrow
RIS

Find record

In BMC

Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma

Find record

Citation metrics

Archiving options